Intravenous sub-anesthetic ketamine for perioperative analgesia

• Main Authors: Andrew W Gorlin, David M Rosenfeld, Harish Ramakrishna
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2016-01-01
• Series: Journal of Anaesthesiology Clinical Pharmacology
• Subjects: Ketamine, N-methyl-d-aspartate, pain
• Online Access: http://www.joacp.org/article.asp?issn=0970-9185;year=2016;volume=32;issue=2;spage=160;epage=167;aulast=Gorlin

Ketamine, an N-methyl-d-aspartate antagonist, blunts central pain sensitization at sub-anesthetic doses (0.3 mg/kg or less) and has been studied extensively as an adjunct for perioperative analgesia. At sub-anesthetic doses, ketamine has a minimal physiologic impact though it is associated with a low incidence of mild psychomimetic symptoms as well as nystagmus and double vision. Contraindications to its use do exist and due to ketamine′s metabolism, caution should be exercised in patients with renal or hepatic dysfunction. Sub-anesthetic ketamine improves pain scores and reduces perioperative opioid consumption in a broad range of surgical procedures. In addition, there is evidence that ketamine may be useful in patients with opioid tolerance and for preventing chronic postsurgical pain.